Stanley Hostler - Protea Biosciences Insider

PRGB -- USA Stock  

USD 0.04  0.00  0.00%

VP, Secretary, Director and Member of Audit Committee

Mr. Stanley Hostler is Vice President, Secretary, Director of the Company. He was a Director of the Company since January 2006 and Vice President and Secretary since June 2006. Mr. Hostler is an attorney with a career practice in the field of labor and employment law. From 2000 to 2010 he served as Special Assistant to the Governor of the State of West Virginia. From 2002 to 2004 he served as Counsel to the Prim Law Firm. From 2000 to 2010 he served on the West Virginia University Foundation Board of Directors, and from 1995 to 2010 on the Advisory Committee of the WVU School of Medicine. He is a Graduate of the West Virginia University School of Law . Mr. Hostlers legal experience and business contacts and relationships with West Virginia University and the State of West Virginia have been an asset to the Company and led the board to determine that he should serve as a director of the Company.
Age: 86        
304-292-2226  http://www.proteabio.com

Stanley Hostler Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (104.33) % which means that it has lost $104.33 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (31.9) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 10.93 M in liabilities. Protea Biosciences Group has Current Ratio of 0.04 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. Protea Biosciences Group (PRGB) is traded on OTC Market in USA. It is located in WEST VIRGINIA, U.S.A and employs 35 people. Protea Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Protea Biosciences G Leadership Team

Leonard Harris, Director
Stephen Turner, Chairman
Gregory Kilby, COO, Ph.D
Edwin Roberson, Director
Stanley Hostler, Director
Steven Antoline, Director
Edward Hughes, CFO
Scott Segal, Director
Ed Roberson, Director
Patrick Gallagher, Director, CFA
Andrew Zulauf, Director, MBA
Josiah Austin, Director
Matthew Powell, VP, Ph.D
David Halverson, President
Maged Shenouda, Director, MBA

Stock Performance Indicators

Current Sentiment - PRGB

Protea Biosciences G Investor Sentiment
Most of Macroaxis users are at this time bullish on Protea Biosciences Group. What is your perspective on investing in Protea Biosciences Group? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
OZL   
Purchased over 100 shares of
over a week ago
Traded for 10.44
FBU   
Purchased over 300 shares of
over a week ago
Traded for 6.24
JBH   
Purchased over 70 shares of
over a week ago
Traded for 23.42
GNC   
Purchased over 200 shares of
over a week ago
Traded for 8.1
SBM   
Purchased over 400 shares of
over a week ago
Traded for 4.74
Additionally take a look at Your Equity Center. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.